From GlobeNewswire: 2024-11-15 09:00:00

The Pharmaceutical Sterility Testing Market was valued at USD 1.42 Billion in 2023 and is projected to reach USD 3.79 Billion by 2032, growing at a CAGR of 11.58%. The market is driven by rising demand for safe products and technological advancements, with biopharmaceuticals offering emerging opportunities for sterility testing.

Major players in the market include Pacific Biolabs, Steris Plc, Boston Analytical, Sotera Health Company, and Sartorius Ag. The market report covers key segments, such as by type, product type, and end-use, and highlights cost barriers limiting adoption of advanced sterility testing solutions.

Pharmaceutical sterility testing is crucial for ensuring drug safety and upholding pharmaceutical quality. Rigorous testing is essential to prevent microbial contamination and maintain product quality and efficacy, building trust with consumers. Innovations in rapid detection and automation are transforming sterility testing, leading to faster, more reliable results.

Outsourcing dominates the pharmaceutical sterility testing market, with in-house testing expected to show the fastest growth due to advances in automation and AI. North America currently dominates the market, but Asia Pacific is projected to have the highest growth potential due to pharmaceutical manufacturing growth and healthcare infrastructure investments. The demand for proper sterility testing solutions in China and India is increasing due to the growth of generics and biologics, as well as the rise of contract manufacturing organizations. This growth is driven by the region’s push for international quality standards, leading to a surge in the pharmaceutical sterility testing market.

In 2024, Sartorius unveiled the Sterisart Universal | Gen 4 sterility testing pump, offering real-time data sharing and secure electronic documentation to enhance pharmaceutical testing workflows. STERIS also launched Verafit Sterilization Bags and Covers to aid in EU GMP Annex 1 compliance and reduce contamination risks in pharmaceutical sterilization processes.

Key developments in the pharmaceutical sterility testing market include technological trends, regulatory compliance standards, outsourcing trends, and statistical insights on demand by drug type. The market also features a competitive landscape with major companies listed by region, along with market share analysis and technological advancements.

For deeper insights into the pharmaceutical sterility testing market, consult with expert analysts at S&S Insider, a leading market research and consulting agency. They provide current and accurate market data, consumer insights, and opinions to help clients make informed decisions in a changing business environment. Contact them for customized research and consultation services.



Read more at GlobeNewswire: Pharmaceutical Sterility Testing Market to Drive Revenue to